Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Epidiolex with Stiripentol or Valproate in Epilepsy
NCT02607891Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Nov 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of cannabidiol in epilepsy, sponsored by Jazz Pharmaceuticals plc. Started Nov 2016; status: completed.
02
Drugs
cannabidiol
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02607891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607891.